TC09644 ****** - [2025] UKFTT 01121 (TC)
First-tier Tribunal (Tax Chamber)

TC09644 ****** - [2025] UKFTT 01121 (TC)

Fecha: 25-Jul-2025

Medication

Medication

91.

The various reports detail the following, concerning PO’s medication:

(1)

8 November 2016 - Fluoxetine was augmented with Mirtazapine 15 mg nocte

(2)

16 November 2016 - the antidepressant Fluoxetine was stopped.

(3)

28 November 2016 – Mirtazapine was increased to 30 mg.

(4)

16 March 2017 - Mirtazapine was increased to 45 mg.

(5)

“Recently, he has had his Mirtazapine augmented with the antidepressant Venlafaxine. In my opinion, this is a very strong combination and reflects the severity of his depressive disorder.” (Venlafaxine 37.5 mg): RB2 §4.2; 9.3